Regeneron and Lilly have developed spike MABs.. they're becoming useless fairly quickly as new variants arise.
Nothing is approved for severe / critical that actually works on the disease and not the symptoms.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-